Nitric oxide increases endocervical secretion at the ovulatory phase in the female

Nitric oxide donors increase the pregnancy rate in patients with unexplained infertility undergoing clomiphene citrate stimulation and intrauterine insemination: a randomized controlled pilot study

This study evaluated the effects of nitric oxide donor's treatment on the pregnancy rate and uterine blood flow in patients with unexplained infertility undergoing clomiphene citrate stimulation and intrauterine insemination. A total of 120 patients were randomly allocated to a control group who received 100 mg clomiphene citrate daily from day 5 to 9 of cycle plus placebo vaginal tablets, and a study group received clomiphene citrate plus isosorbide mononitrate 10 mg vaginal tablets. Vaginal ultrasound was done before treatment and every other day starting from day 12 of cycle to count mature follicles and ovulation was triggered by IM injection of 10 000 IU hCG when one follicle measured 18 ≥ mm followed by intrauterine insemination after 36 h. The endometrial thickness, uterine arteries resistance and pulsation indices, and endometrial vascular flow and vascular flow indices were measured before treatment and at day of hCG injection. Results were analyzed after one cycle treatment using the Mean ± SD, the Student t test and the Fisher Exact test. Significant result was considered at p values <0.05. The study group had significant higher pregnancy rate/cycle, higher endometrial and lower uterine artery blood flow indices (p < 0.05).

Midcycle pericoital intravaginal bee honey and royal jelly for male factor infertility

OBJECTIVE

To evaluate the efficacy of pericoital intravaginal applications of a mixture of Egyptian bee honey and royal jelly (H/RJ) in the midcycle for the treatment of infertility due to asthenozoospermia.

METHODS

Sohag University Hospital and Asyut Gynecology and Infertility Clinic conducted a crossover study of 99 couples affected by asthenozoospermia. One group used midcycle pericoital vaginal applications of H/RJ and the other underwent a standard intrauterine insemination (IUI) procedure, for 3 cycles or until conception occurred for both groups. After a washout period of 2 months, the couples for whom no pregnancy occurred were crossed over.

RESULTS

A total of 553 cycles were analyzed. There were 23 (8.1%) and 7 (2.6%) pregnancies per cycle, respectively, in the H/RJ and the IUI groups, and the difference was statistically significant (P<0.001).

CONCLUSION

Using H/RJ intravaginally might be a simple and reasonably effective method of treating asthenozoospermia.